News
Herantis Pharma has dosed the first patients in the final cohort of its phase 1b clinical trial assessing HER-096, a ...
Kaerus Bioscience has received orphan drug and rare paediatric drug designations from the FDA for KER-0193, its lead ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback